Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Turkey Health Minister Tells Envoy Access To U.S. Drug Market Would Pave Way For Import Review

This article was originally published in PharmAsia News

Executive Summary

The Turkish health ministry has turned the tables in response to a complaint by the U.S. ambassador on the time it takes to get a license to import drugs. Global drug companies have stepped up complaints on the import process since a GMP certificate from Turkey’s health ministry became mandatory in 2010.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC083881

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel